MENU
+Compare
DVAX
Stock ticker: NASDAQ
AS OF
Dec 4, 04:49 PM (EDT)
Price
$10.97
Change
-$0.00 (-0.00%)
Capitalization
1.29B

DVAX Dynavax Technologies Corp Forecast, Technical & Fundamental Analysis

Dynavax Technologies Corp is a biopharmaceutical company... Show more

Industry: #Biotechnology
DVAX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for DVAX with price predictions
Dec 03, 2025

Aroon Indicator for DVAX shows an upward move is likely

DVAX's Aroon Indicator triggered a bullish signal on November 24, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 196 similar instances where the Aroon Indicator showed a similar pattern. In of the 196 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DVAX advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .

DVAX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for DVAX moved out of overbought territory on November 13, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 01, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on DVAX as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for DVAX turned negative on December 01, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DVAX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DVAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DVAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.411) is normal, around the industry mean (17.291). P/E Ratio (54.600) is within average values for comparable stocks, (72.992). DVAX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.950). DVAX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.029). P/S Ratio (4.098) is also within normal values, averaging (64.427).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
DVAX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

DVAX is expected to report earnings to fall 78.57% to 4 cents per share on February 19

Dynavax Technologies Corp DVAX Stock Earnings Reports
Q4'25
Est.
$0.05
Q3'25
Beat
by $0.08
Q2'25
Beat
by $0.04
Q1'25
Missed
by $0.81
Q4'24
Beat
by $0.01
The last earnings report on November 05 showed earnings per share of 20 cents, beating the estimate of 12 cents. With 433.89K shares outstanding, the current market capitalization sits at 1.29B.
A.I. Advisor
published General Information

General Information

a developer of novel products to prevent and treat infectious diseases

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2100 Powell Street
Phone
+1 510 848-5100
Employees
408
Web
https://www.dynavax.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WESWX10.070.06
+0.60%
TETON Westwood Equity AAA
FTCHX74.520.23
+0.31%
Invesco Technology Investor
SRUAX15.850.04
+0.25%
Meeder Spectrum Adviser
MNOPX32.340.01
+0.03%
Morgan Stanley Inst International Opp R6
JEMCX38.28N/A
N/A
JPMorgan Emerging Markets Equity C

DVAX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with ACET. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
+0.83%
ACET - DVAX
39%
Loosely correlated
-4.12%
SNDL - DVAX
35%
Loosely correlated
+2.35%
ALKS - DVAX
32%
Poorly correlated
+1.93%
COLL - DVAX
28%
Poorly correlated
+0.72%
TLRY - DVAX
27%
Poorly correlated
-8.43%
More

Groups containing DVAX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
+0.83%
Pharmaceuticals: Generic
industry (213 stocks)
33%
Loosely correlated
+0.61%